SCHEMBL10179413

SCHEMBL10179413

O=C(O)c1ccc(C2CCN(C(=O)O)CC2)cn1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.68
L3MBTL1 Q9Y468 2/20 0.68
GLA P06280 1/20 0.68
HTT P42858 1/20 0.68
KMT2A Q03164 1/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
HIF1A Q16665 1/20 0.68
TDP1 Q9NUW8 1/20 0.68
P4HTM Q9NXG6 2/20 0.42
P4HA1 P13674 1/20 0.42
MIF P14174 1/20 0.42
TRPC6 Q9Y210 2/20 0.42
ALDH1A1 P00352 1/20 0.41
QDPR P09417 1/20 0.39
SCD5 Q86SK9 2/20 0.39
USP5 P45974 2/20 0.38
BACE1 P56817 1/20 0.38
L3MBTL3 Q96JM7 1/20 0.38
NAMPT P43490 1/20 0.38
GPR119 Q8TDV5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27392629 0.88 KDM4E (0.64) KDM4EL3MBTL1GLAHTTKMT2A
SCHEMBL1585290 0.85 KDM4E (0.83) KDM4EL3MBTL1GLAHTTKMT2A
SCHEMBL24244905 0.85 KDM4E (0.68) KDM4EL3MBTL1GLAHTTKMT2A
SCHEMBL27282972 0.85 KDM4E (0.59) KDM4EL3MBTL1GLAHTTKMT2A
SCHEMBL14151857 0.82 KDM4E (0.97) KDM4EL3MBTL1GLAHTTKMT2A
SCHEMBL609605 0.82 TRPC6 (0.52) KDM4EL3MBTL1GLAHTTKMT2A
SCHEMBL30783142 0.82 TRPC6 (0.52) KDM4EL3MBTL1GLAHTTKMT2A
SCHEMBL10180063 0.82 GPR119 (0.59) KDM4EL3MBTL1GLAHTTKMT2A
SCHEMBL1577753 0.79 KDM4E (0.42) KDM4EL3MBTL1GLAHTTKMT2A
SCHEMBL12489379 0.78 FASN (0.47) KDM4EL3MBTL1GLAHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120245344-A1 GPR119 AGONIST NIPPON CHEMIPHAR CO., LTD. (JP) 2012-09-27 US disclosed
EP-2474540-A1 GPR119 AGONIST Nippon Chemiphar Co., Ltd. (JP) 2012-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120245344-A1 GPR119 AGONIST GPR119, GPR4, GPR55 KDM4E 2502/4885L3MBTL1 1719/4885GLA 3584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.